MRNA stock news
This page provides real-time market news, earnings updates, and company announcements related to Moderna, Inc. (MRNA).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-06-01 00:32 EST
Biotechnology giant Moderna, Inc. announced that it has committed to pay its partner Arbutus Biopharma and its subsidiary Genevant Sciences an unconditional one-time payment of up to 950 millions USD on or before July 8, 2026.
老虎证券2026-03-05 11:24:28
Berenberg raises Moderna's target price to $45
格隆汇2026-03-06 08:12:57
美疫苗股集体下挫！特朗普竟任命反疫苗人士担任美国卫生部长
moomoo-证劵2026-03-08 14:36:33
Why Is uniQure Stock Skyrocketing Monday?
Finviz2026-03-09 11:06:50
What's Going On With Moderna, Capricor, Other Biotech Stocks On Monday?
Finviz2026-03-09 17:33:53
BioNTech Stock Tumbles As Co-Founders Pivot To New MRNA Venture
Finviz2026-03-10 12:57:51
CytomX's Varsetatug Masetecan (EpCAM PROBODY ADC) Continues to Demonstrate Positive Data Supporting Potential as a New Treatment Option in Late-Line Colorectal Cancer
Finviz2026-03-16 11:03:45
CytomX Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Finviz2026-03-16 20:09:45
CytomX Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Finviz2026-03-16 20:09:45
CytomX Therapeutics Announces Pricing of $250 Million Offering of Common Stock and Pre-Funded Warrants
Finviz2026-03-18 02:52:13
Deutsche Bank raises Moderna's target price to $45
格隆汇2026-03-19 09:26:26
Pyxis Oncology Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
Finviz2026-03-23 11:04:13
Arbutus Reports Fourth Quarter and Year End 2025 Financial Results and Provides Corporate Update
Finviz2026-03-23 11:36:10
Eikon Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Clinical and Corporate Updates
Finviz2026-03-30 11:51:48
Barclays raises Moderna's target price to $48
格隆汇2026-04-03 08:59:02
CureVac sues Moderna over COVID-19 vaccine patent infringement
格隆汇2026-04-27 02:29:31
On May 1st, Moderna surged over 10% in pre-market trading! First-quarter results exceeded market expectations, reaffirming the plan to achieve 10% revenue growth by 2026
老虎证券2026-05-01 10:58:33
US stocks moving | Moderna continues to rise nearly 7% pre-market, advancing multiple early-stage studies related to hantavirus vaccines
格隆汇2026-05-11 08:30:58
Dow Jones Industrial Average steady as Iran rebuff lifts Oil, CPI in focus
FXStreet2026-05-11 16:39:46
Another global pandemic on the way? Hantavirus concerns escalate, this stock soars 22% in two days
金融界2026-05-11 23:53:11
Bitget UEX Daily | Circle Completes $222 Million ARC Pre-Sale; US CPI Data Incoming; US-Iran Ceasefire Agreement in Jeopardy (May 12, 2026)
Bitget2026-05-12 01:27:26
The Hantavirus Scare Brought 3 Covid-Era Stocks Back in the Spotlight
BeInCrypto2026-05-12 21:06:12
US Stocks Movement | A new Ebola outbreak in Africa leads to a broad surge in biotech vaccine concept stocks
格隆汇2026-05-20 14:39:42
JPMorgan sets Moderna's target price at 40 dollars
格隆汇2026-05-21 09:24:36
What's Going On With Moderna, Capricor, Other Biotech Stocks On Monday?
Finviz2026-03-09 17:33:53
BioNTech Stock Tumbles As Co-Founders Pivot To New MRNA Venture
Finviz2026-03-10 12:57:51
CytomX's Varsetatug Masetecan (EpCAM PROBODY ADC) Continues to Demonstrate Positive Data Supporting Potential as a New Treatment Option in Late-Line Colorectal Cancer
Finviz2026-03-16 11:03:45
CytomX Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Finviz2026-03-16 20:09:45
CytomX Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Finviz2026-03-16 20:09:45
CytomX Therapeutics Announces Pricing of $250 Million Offering of Common Stock and Pre-Funded Warrants
Finviz2026-03-18 02:52:13
Deutsche Bank raises Moderna's target price to $45
格隆汇2026-03-19 09:26:26
Pyxis Oncology Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
Finviz2026-03-23 11:04:13
Arbutus Reports Fourth Quarter and Year End 2025 Financial Results and Provides Corporate Update
Finviz2026-03-23 11:36:10
Eikon Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Clinical and Corporate Updates
Finviz2026-03-30 11:51:48
Barclays raises Moderna's target price to $48
格隆汇2026-04-03 08:59:02
CureVac sues Moderna over COVID-19 vaccine patent infringement
格隆汇2026-04-27 02:29:31
On May 1st, Moderna surged over 10% in pre-market trading! First-quarter results exceeded market expectations, reaffirming the plan to achieve 10% revenue growth by 2026
老虎证券2026-05-01 10:58:33
US stocks moving | Moderna continues to rise nearly 7% pre-market, advancing multiple early-stage studies related to hantavirus vaccines
格隆汇2026-05-11 08:30:58
Dow Jones Industrial Average steady as Iran rebuff lifts Oil, CPI in focus
FXStreet2026-05-11 16:39:46
Another global pandemic on the way? Hantavirus concerns escalate, this stock soars 22% in two days
金融界2026-05-11 23:53:11
Bitget UEX Daily | Circle Completes $222 Million ARC Pre-Sale; US CPI Data Incoming; US-Iran Ceasefire Agreement in Jeopardy (May 12, 2026)
Bitget2026-05-12 01:27:26
The Hantavirus Scare Brought 3 Covid-Era Stocks Back in the Spotlight
BeInCrypto2026-05-12 21:06:12
US Stocks Movement | A new Ebola outbreak in Africa leads to a broad surge in biotech vaccine concept stocks
格隆汇2026-05-20 14:39:42
JPMorgan sets Moderna's target price at 40 dollars
格隆汇2026-05-21 09:24:36
MRNA stock chart
MRNA stock detailsMRNA stock price change
On the last trading day, MRNA stock closed at 47.19 USD, with a price change of -0.80% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more